G1 sees stock bump on big data readout

Research Triangle Park-based G1 Therapeutics saw its stock up more than 8 percent Monday afternoon, trading north of $27 per share following a big data readout.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.